Skip to main content
Top
Published in: Endocrine 1/2010

01-02-2010 | Original Article

Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome

Authors: Djuro Macut, Danijela Vojnović Milutinović, Ivana Božić, Gordana Matić, Jelena Brkljačić, Dimitrios Panidis, Milan Petakov, Nikolaos Spanos, Jelica Bjekić, Olivera Stanojlović, Anđela Petrović Milinković, Zoran Radojičić, Svetozar Damjanović

Published in: Endocrine | Issue 1/2010

Login to get access

Abstract

Glucocorticoid receptor (GR) transduces the glucocorticoid (GC) signal that could lead to metabolic derangements depending on the tissue responsiveness to GC. We aimed to investigate possible causative relation of the GR functional properties in peripheral blood mononuclear cells of women with polycystic ovary syndrome (PCOS), with their clinical and biochemical characteristics. Thirty women with PCOS [mean age: 26.5 ± 5.1 years, mean body mass index (BMI) 24.5 ± 5 kg/m2], and thirty respective controls were analyzed for the number of GR sites per cell (B max), apparent equilibrium dissociation constant (K d), and binding potency (GR potency). A strong association between B max and K d (r = 0.70, P < 0.0001), and GR potency with age (r = 0.49, P = 0.009) was observed in PCOS women. The multiple regression analyses within the PCOS group revealed that independent predictors for K d were BMI, total cholesterol, and dehydroepiandrosterone-sulfate (DHEA-S) (r = 0.58, P = 0.038), while for GR potency (r = 0.687, P = 0.013) were age, BMI, DHEA-S, and basal cortisol concentration. The results suggest that PCOS pathophysiology may be related to alterations of a cross stalk between glucocorticoid signaling, age, and metabolic parameters. These findings should be further explored in studies on the role of GR in PCOS-related metabolic derangements.
Literature
3.
go back to reference R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, J. Clin. Endocrinol. Metab. 89, 2745–2749 (2004)CrossRefPubMed R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, J. Clin. Endocrinol. Metab. 89, 2745–2749 (2004)CrossRefPubMed
4.
go back to reference T.F. Gallagher, A. Kappas, L. Hellman, M.B. Lipsett, O.H. Pearson, C.D. West, J. Clin. Invest. 37, 794–799 (1958)CrossRefPubMed T.F. Gallagher, A. Kappas, L. Hellman, M.B. Lipsett, O.H. Pearson, C.D. West, J. Clin. Invest. 37, 794–799 (1958)CrossRefPubMed
5.
9.
go back to reference A. Gambineri, V. Vicennati, S. Genghini, F. Tomassoni, U. Pagotto, R. Pasquali, B.R. Walker, J. Clin. Endocrinol. Metab. 91, 2295–2302 (2006)CrossRefPubMed A. Gambineri, V. Vicennati, S. Genghini, F. Tomassoni, U. Pagotto, R. Pasquali, B.R. Walker, J. Clin. Endocrinol. Metab. 91, 2295–2302 (2006)CrossRefPubMed
10.
12.
go back to reference D. Macut, S. Damjanovic, D. Panidis, N. Spanos, B. Glisic, M. Petakov, D. Rousso, A. Kourtis, J. Bjekic, N. Milic, Eur. J. Endocrinol. 155, 131–136 (2006)CrossRefPubMed D. Macut, S. Damjanovic, D. Panidis, N. Spanos, B. Glisic, M. Petakov, D. Rousso, A. Kourtis, J. Bjekic, N. Milic, Eur. J. Endocrinol. 155, 131–136 (2006)CrossRefPubMed
13.
go back to reference D. Macut, D. Panidis, B. Glisic, N. Spanos, M. Petakov, J. Bjekic, O. Stanojlovic, D. Rousso, A. Kourtis, I. Bozic, S. Damjanovic, Can. J. Physiol. Pharmacol. 86, 199–204 (2008)CrossRefPubMed D. Macut, D. Panidis, B. Glisic, N. Spanos, M. Petakov, J. Bjekic, O. Stanojlovic, D. Rousso, A. Kourtis, I. Bozic, S. Damjanovic, Can. J. Physiol. Pharmacol. 86, 199–204 (2008)CrossRefPubMed
14.
go back to reference G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)CrossRefPubMed G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)CrossRefPubMed
15.
go back to reference R.A. Covar, D.Y. Leung, D. McCormick, J. Steelman, P. Zeitler, J.D. Spahn, J. Allergy Clin. Immunol. 106, 651–659 (2000)CrossRefPubMed R.A. Covar, D.Y. Leung, D. McCormick, J. Steelman, P. Zeitler, J.D. Spahn, J. Allergy Clin. Immunol. 106, 651–659 (2000)CrossRefPubMed
16.
go back to reference B.R. Walker, D.I.W. Phillips, J.P. Noon, M. Panarelli, R. Andrew, H.V. Edwards, D.W. Holton, J.R. Seckl, D.J. Webb, G.C. Watt, Hypertension 31, 891–895 (1998)PubMed B.R. Walker, D.I.W. Phillips, J.P. Noon, M. Panarelli, R. Andrew, H.V. Edwards, D.W. Holton, J.R. Seckl, D.J. Webb, G.C. Watt, Hypertension 31, 891–895 (1998)PubMed
17.
go back to reference Yu.A. Shakhov, I.E. Petrichenko, N.V. Chepurnenko, N.V. Perova, R.G. Oganov, Biochem. Int. 18, 913–922 (1989)PubMed Yu.A. Shakhov, I.E. Petrichenko, N.V. Chepurnenko, N.V. Perova, R.G. Oganov, Biochem. Int. 18, 913–922 (1989)PubMed
19.
go back to reference X.K. Zhang, J.M. Dong, J.F. Chiu, J. Biol. Chem. 266, 8248–8254 (1991)PubMed X.K. Zhang, J.M. Dong, J.F. Chiu, J. Biol. Chem. 266, 8248–8254 (1991)PubMed
22.
go back to reference I. Elakovic, T. Perisic, M. Cankovic-Kadijevic, G. Matic, Cell Biochem. Funct. 25, 427–431 (2007)CrossRefPubMed I. Elakovic, T. Perisic, M. Cankovic-Kadijevic, G. Matic, Cell Biochem. Funct. 25, 427–431 (2007)CrossRefPubMed
25.
26.
go back to reference M. Fassnacht, N. Schlenz, S.B. Schneider, S.A. Wudy, B. Allolio, W. Arlt, J. Clin. Endocrinol. Metab. 88, 2760–2766 (2003)CrossRefPubMed M. Fassnacht, N. Schlenz, S.B. Schneider, S.A. Wudy, B. Allolio, W. Arlt, J. Clin. Endocrinol. Metab. 88, 2760–2766 (2003)CrossRefPubMed
28.
go back to reference T. Hirotoshi, H. Akama, Y. Ichikawa, M. Homma, H. Oshima, Clin. Chem. 37, 1715–1719 (1991) T. Hirotoshi, H. Akama, Y. Ichikawa, M. Homma, H. Oshima, Clin. Chem. 37, 1715–1719 (1991)
29.
go back to reference F. Then-Bergh, A. Grasser, C. Trenkwalder, H. Backmund, F. Holsober, R. Rupprecht, J. Neurol. 246, 292–298 (1999)CrossRefPubMed F. Then-Bergh, A. Grasser, C. Trenkwalder, H. Backmund, F. Holsober, R. Rupprecht, J. Neurol. 246, 292–298 (1999)CrossRefPubMed
31.
go back to reference T. Shimada, N. Hiwatashi, H. Yamayaki, Y. Kinouchi, T. Toyota, Dis. Colon Rectum 40(10 Suppl), S54–S58 (1997)CrossRefPubMed T. Shimada, N. Hiwatashi, H. Yamayaki, Y. Kinouchi, T. Toyota, Dis. Colon Rectum 40(10 Suppl), S54–S58 (1997)CrossRefPubMed
32.
go back to reference T. Hirano, A. Horigome, K. Oka, H. Takeuchi, M. Yoshida, E. Sakurai, K. Kozaki, N. Matsuno, T. Nagao, M. Kozaki, Immunopharmacology 36, 57–67 (1997)CrossRefPubMed T. Hirano, A. Horigome, K. Oka, H. Takeuchi, M. Yoshida, E. Sakurai, K. Kozaki, N. Matsuno, T. Nagao, M. Kozaki, Immunopharmacology 36, 57–67 (1997)CrossRefPubMed
33.
go back to reference S. Sanden, R. Tripmacher, R. Weltrich, W. Rohde, F. Hiepe, G.R. Burmester, F. Buttgereit, J. Rheumatol. 27, 1265–1270 (2000)PubMed S. Sanden, R. Tripmacher, R. Weltrich, W. Rohde, F. Hiepe, G.R. Burmester, F. Buttgereit, J. Rheumatol. 27, 1265–1270 (2000)PubMed
34.
go back to reference N.A. Huizenga, J.W. Koper, P. De Lange, H.A. Pols, R.P. Stolk, H. Burger, D.E. Grobbee, A.O. Brinkmann, F.H. De Jong, S.W. Lamberts, J. Clin. Endocrinol. Metab. 83, 144–151 (1998)CrossRefPubMed N.A. Huizenga, J.W. Koper, P. De Lange, H.A. Pols, R.P. Stolk, H. Burger, D.E. Grobbee, A.O. Brinkmann, F.H. De Jong, S.W. Lamberts, J. Clin. Endocrinol. Metab. 83, 144–151 (1998)CrossRefPubMed
36.
go back to reference A.M. Di Blasio, E.F. van Rossum, S. Maestrini, M.E. Berselli, M. Tagliaferri, F. Podesta, J.W. Koper, A. Luizzi, S.W. Lamberts, Clin. Endocrinol. 59, 68–74 (2003)CrossRef A.M. Di Blasio, E.F. van Rossum, S. Maestrini, M.E. Berselli, M. Tagliaferri, F. Podesta, J.W. Koper, A. Luizzi, S.W. Lamberts, Clin. Endocrinol. 59, 68–74 (2003)CrossRef
38.
go back to reference S. Saponaro, V. Guarnieri, G.P. Pescarmona, F. Silvagno, J. Steroid Biochem. Mol. Biol. 103, 129–136 (2007)CrossRefPubMed S. Saponaro, V. Guarnieri, G.P. Pescarmona, F. Silvagno, J. Steroid Biochem. Mol. Biol. 103, 129–136 (2007)CrossRefPubMed
39.
go back to reference The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Fertil. Steril. 81, 19–25 (2004) The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Fertil. Steril. 81, 19–25 (2004)
40.
go back to reference D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Diabetologia 28, 412–419 (1985)CrossRefPubMed D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Diabetologia 28, 412–419 (1985)CrossRefPubMed
41.
go back to reference W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Clin. Chem. 18, 499–502 (1972)PubMed W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Clin. Chem. 18, 499–502 (1972)PubMed
42.
go back to reference R.S. Mathur, L.O. Moody, S. Landgrebbe, H.O. Williamson, Fertil. Steril. 35, 29–37 (1981)PubMed R.S. Mathur, L.O. Moody, S. Landgrebbe, H.O. Williamson, Fertil. Steril. 35, 29–37 (1981)PubMed
Metadata
Title
Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome
Authors
Djuro Macut
Danijela Vojnović Milutinović
Ivana Božić
Gordana Matić
Jelena Brkljačić
Dimitrios Panidis
Milan Petakov
Nikolaos Spanos
Jelica Bjekić
Olivera Stanojlović
Anđela Petrović Milinković
Zoran Radojičić
Svetozar Damjanović
Publication date
01-02-2010
Publisher
Springer US
Published in
Endocrine / Issue 1/2010
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9277-9

Other articles of this Issue 1/2010

Endocrine 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.